1,395
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Ficus recemosa bark extract attenuates diabetic complications and oxidative stress in STZ-induced diabetic rats

, , , , , , & show all
Pages 1586-1595 | Received 07 Jan 2015, Accepted 10 Oct 2015, Published online: 10 Feb 2016

References

  • Ahmed F, Urooj A. 2010a. Traditional uses, medicinal properties, and phytopharmacology of Ficus racemosa: a review. Pharm Biol. 48:672–681.
  • Ahmed F, Urooj A. 2010b. In vitro studies on the hypoglycemic potential of Ficus racemosa stem bark. J Sci Food Agric. 90:397–401.
  • Ahmed F, Urooj A. 2012. Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity. Pharm Biol. 50:468–473.
  • American Diabetes Association. 2013. Diagnosis and classification of diabetes mellitus. Diabetes Care 36: S67–S74.
  • Balakumar P, Singh M. 2006. The possible role of caspase-3 in pathological and physiological cardiac hypertrophy in rats. Basic Clin Pharmacol Toxicol. 99:418–424.
  • Cai L. 2006. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic Biol Med. 41:851–861.
  • Cai L, Kang YJ. 2001. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol. 1:181–193.
  • Don BR, Kaysen G. 2010. Serum albumin concentration and chronic kidney disease. US Nephrol. 5:20–27.
  • Doumas BT, Watson WA, Biggs HG. 1971. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta. 31:87–96.
  • Drobnik J, Ciosek J, Slotwinska D, Stempniak B, Zukowska D, Marczynski A, Tosik D, Bartel H, Dabrowski R, Szczepanowska A. 2009. Experimental hypothyroidism increases content of collagen and glycosaminoglycans in the heart. J Physiol Pharmacol. 60:57–62.
  • Evans WC. 2002. Trease and Evans' pharmacognosy. London: WB Saunders Harcourt Publishers Ltd.
  • Fischer GW, Hunter KW, Wilson SR. 1982. Modified human immune serum globulin for intravenous administration: in vitro opsonic activity and in vivo protection against group B streptococcal disease in suckling rats. Acta Paediatr Scand. 71:639–644.
  • Galkina E, Ley K. 2006. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol. 17:368–377.
  • Gilbert RE, Connelly K, Kelly DJ, Pollock CA, Krum H. 2006. Heart failure and nephropathy: catastrophic and interrelated complications of diabetes. Clin J Am Soc Nephrol. 1:193–208.
  • Huang EJ, Kuo WW, Chen YJ, Chen TH, Chang MH, Lu MC, Tzang BS, Hsu HH, Huang CY, Lee SD. 2006. Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. Clin Chim Acta. 366:293–298.
  • Kassirer JP. 1971. Clinical evaluation of kidney function–glomerular function. N Engl J Med. 285:385–389.
  • Khan N, Sultana S. 2005. Chemomodulatory effect of Ficus racemosa extract against chemically induced renal carcinogenesis and oxidative damage response in Wistar rats. Life Sci. 77:1194–1210.
  • Krishnamoorthi V, Divianathan S, Subramanian B, Manoharan S. 2007. Antihyperglycemic and antilipidperoxidative effects of Ficus racemosa (Linn.) bark extracts in alloxan induced diabetic rats. J Med Sci. 7:330–338.
  • Lenzen S. 2008. Oxidative stress: the vulnerable beta-cell. Biochem Soc Trans. 36:343–347.
  • Li B, Liu S, Miao L, Cai L. 2012. Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy. Exp Diabetes Res. 2012:216512.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275.
  • Manian R, Anusuya N, Siddhuraju P, Manian S. 2008. The antioxidant activity and free radical scavenging potential of two different solvent extracts of Camellia sinensis (L.) O. Kuntz, Ficus bengalensis L. and Ficus racemosa L. Food Chem. 107:1000–1007.
  • Misra HP, Fridovich I. 1972. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 247:3170–3175.
  • Mohan V, Sudha V, Radhika G, Radha V, Rema M, Deepa R. 2007. Gene-environment interactions and the diabetes epidemic in India. Tai ES, Gillies PJ, editors. 1st ILSI International Conference on Nutrigenomics: Nutrigenomics - Opportunities in Asia. Forum of nutrition. Vol. 60. Singapore: Karger. p. 118–26.
  • Mollik MAH, Hossan MS, Paul AK, Taufiq-Ur-Rahman M, Jahan R, Rahmatullah M. 2010. A comparative analysis of medicinal plants used by folk medicinal healers in three districts of Bangladesh and inquiry as to mode of selection of medicinal plants. Ethnobot Res Appl. 8:195–218.
  • Moron MS, Depierre JW, Mannervik B. 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta. 582:67–78.
  • Nikhil KS, Yatindra K, Seema P, Thakur RN, Sudhir SG. 2009. Antidiabetic potential of alcoholic and aqueous extracts of Ficus racemosa Linn. bark in normal and alloxan induced diabetic rats. Int J Pharm Sci Drug Res. 1:24–27.
  • Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358.
  • Ozgur O, Akalin PP, Nuri B, Fatih H. 2009. Pathological changes in the acute phase of streptozotocin-induced diabetic rats. Bull Vet Inst Pulawy. 53:783–790.
  • Paarakh PM. 2009. Ficus racemosa Linn. – an overview. Nat Prod Radiac. 8:84–90.
  • Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. 2001. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 345:870–878.
  • Pasupathi P, Rao YY, Farook J, Saravanan G, Bakthavathsalam G. 2009. Oxidative stress and cardiac biomarkers in patients with acute myocardial infarction. Eur J Sci Res. 27:275–285.
  • Patel SS, Goyal RK. 2011. Prevention of diabetes-induced myocardial dysfunction in rats using the juice of the Emblica officinalis fruit. Exp Clin Cardiol. 16:87–91.
  • Poornima IG, Parikh P, Shannon RP. 2006. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res. 98:596–605.
  • Ramkumar KM, Vanitha P, Uma C, Suganya N, Bhakkiyalakshmi E, Sujatha J. 2011. Antidiabetic activity of alcoholic stem extract of Gymnema montanum in streptozotocin-induced diabetic rats. Food Chem Toxicol. 49:3390–3394.
  • Rodrigues B, Cam MC, McNeill JH. 1998. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem. 180:53–57.
  • Sayed AA. 2012. Ferulsinaic acid modulates SOD, GSH, and antioxidant enzymes in diabetic kidney. Evid Based Complement Alternat Med. 2012:580104.
  • Shahid SM, Jawed M, Mahboob T. 2005. Ionic and allied variations in normotensive and hypertensive diabetic patients. J Pak Med Assoc. 55:153–158.
  • Siddique HR, Saleem M. 2011. Beneficial health effects of lupeol triterpene: a review of preclinical studies. Life Sci. 88:285–293.
  • Sophia D, Manoharan S. 2008. Hypolipidemic activities of Ficus racemosa Linn. bark in alloxan induced diabetic rats. Afr J Tradit Complement Altern Med. 4:279–288.
  • Trinder P. 1969. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 22:158–161.
  • Veerapur VP, Prabhakar KR, Thippeswamy BS, Bansal P, Srinivasan KK, Unnikrishnan MK. 2012. Antidiabetic effect of Ficus racemosa Linn. stem bark in high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats: a mechanistic study. Food Chem. 132:186–193.
  • Veerapur VP, Thippeswamy BS, Prabhakar KR, Nagakannan P, Shivasharan BD, Bansal P, Sneha SD, Mishra B, Priyadarsini KI, Unnikrishnan MK. 2011. Antioxidant and renoprotective activities of Ficus racemosa Linn. stem bark: bioactivity guided fractionation study. Biomed Prev Nutr. 1:273–281.
  • Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053.
  • Zafar M, Naqvi S, Ahmed M, Kaimkhani ZA. 2009. Altered kidney morphology and enzymes in streptozotocin induced diabetic rats. Int J Morphol. 27:783–790.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.